Tamoxifen induction of angiogenic factor expression in endometrium
Open Access
- 26 February 2002
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 86 (5) , 761-767
Abstract
Tamoxifen is the current therapy of choice for patients with oestrogen receptor positive breast cancer, and it is currently under evaluation as a prophylactic for women at high risk of developing the disease. However, tamoxifen is also known to induce proliferative changes in the endometrium increasing the risk of developing endometrial hyperplasia, polyps and carcinoma. Angiogenesis is an intimate part of this process. For this reason, we have examined the expression of several well characterized angiogenic factors, namely, acidic and basic fibroblast growth factor, thymidine phosphorylase, vascular endothelial growth factor and adrenomedullin in both normal and tamoxifen exposed pre- and postmenopausal endometrium. Vascular density and endothelial proliferation index were also quantified. We found increased expression of acidic and basic fibroblast growth factor and adrenomedullin after treatment with tamoxifen mainly in premenopausal tissue. Vascular density was significantly increased in pre- but not post-menopausal endometrium (P=0.0018) following tamoxifen treatment. These results support the notion that angiogenesis is integral to the response to tamoxifen exposure, and is a potential target with which to block these side effects of tamoxifen.Keywords
This publication has 41 references indexed in Scilit:
- Chemoprevention of Breast CancerSouthern Medical Journal, 2001
- Thymidine phosphorylase expression in normal and hyperplastic endometrium: Figure 1Journal of Clinical Pathology, 2000
- Hypoxia Regulates the Expression of the Adrenomedullin and HIF-1 Genes in Cultured HL-1 CardiomyocytesBiochemical and Biophysical Research Communications, 1999
- Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trialThe Lancet, 1998
- Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised womenThe Lancet, 1998
- Induction of Adrenomedullin by Hypoxia and Cobalt Chloride in Human Colorectal Carcinoma CellsBiochemical and Biophysical Research Communications, 1998
- PCR display identifies tamoxifen induction of the novel angiogenic factor adrenomedullin by a non estrogenic mechanism in the human endometriumOncogene, 1998
- Vascular endothelial growth factor messenger ribonucleic acid expression in human ovarian and endometrial cancerGynecological Endocrinology, 1996
- Heat‐Induced bFGF gene expression in the absence of heat shock element correlates with enhanced AP‐1 binding activityJournal of Cellular Physiology, 1995
- Genomic Structure of Human Adrenomedullin GeneBiochemical and Biophysical Research Communications, 1994